Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Glycolysis inhibition for anticancer treatment.

Pelicano H, Martin DS, Xu RH, Huang P.

Oncogene. 2006 Aug 7;25(34):4633-46. Review.

PMID:
16892078
2.

The Warburg effect and its cancer therapeutic implications.

Chen Z, Lu W, Garcia-Prieto C, Huang P.

J Bioenerg Biomembr. 2007 Jun;39(3):267-74. Review.

PMID:
17551814
3.

The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?

López-Lázaro M.

Anticancer Agents Med Chem. 2008 Apr;8(3):305-12. Review.

PMID:
18393789
4.

Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug.

Cardaci S, Desideri E, Ciriolo MR.

J Bioenerg Biomembr. 2012 Feb;44(1):17-29. doi: 10.1007/s10863-012-9422-7. Review.

PMID:
22328057
5.

Manipulation of glycolysis in malignant tumors: fantasy or therapy?

Sattler UG, Hirschhaeuser F, Mueller-Klieser WF.

Curr Med Chem. 2010;17(2):96-108. Review.

PMID:
19941476
6.

ROS stress in cancer cells and therapeutic implications.

Pelicano H, Carney D, Huang P.

Drug Resist Updat. 2004 Apr;7(2):97-110. Review.

PMID:
15158766
7.

Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.

Yalcin A, Telang S, Clem B, Chesney J.

Exp Mol Pathol. 2009 Jun;86(3):174-9. doi: 10.1016/j.yexmp.2009.01.003. Review.

PMID:
19454274
8.

Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved.

López-Lázaro M.

Expert Opin Ther Targets. 2007 Aug;11(8):1043-53. Review.

PMID:
17665977
9.

Cancer cell metabolism: implications for therapeutic targets.

Jang M, Kim SS, Lee J.

Exp Mol Med. 2013 Oct 4;45:e45. doi: 10.1038/emm.2013.85. Review.

10.

Cancer's craving for sugar: an opportunity for clinical exploitation.

Yeluri S, Madhok B, Prasad KR, Quirke P, Jayne DG.

J Cancer Res Clin Oncol. 2009 Jul;135(7):867-77. doi: 10.1007/s00432-009-0590-8. Review.

PMID:
19415328
11.

Tumor glycolysis as a target for cancer therapy: progress and prospects.

Ganapathy-Kanniappan S, Geschwind JF.

Mol Cancer. 2013 Dec 3;12:152. doi: 10.1186/1476-4598-12-152. Review.

12.

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.

Pathania D, Millard M, Neamati N.

Adv Drug Deliv Rev. 2009 Nov 30;61(14):1250-75. doi: 10.1016/j.addr.2009.05.010. Review.

PMID:
19716393
13.

The cancer cell's "power plants" as promising therapeutic targets: an overview.

Pedersen PL.

J Bioenerg Biomembr. 2007 Feb;39(1):1-12. Review.

PMID:
17404823
14.

Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies.

Sheng H, Niu B, Sun H.

Curr Med Chem. 2009;16(13):1561-87. Review.

PMID:
19442134
15.

Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery.

Talekar M, Boreddy SR, Singh A, Amiji M.

Expert Opin Biol Ther. 2014 Aug;14(8):1145-59. doi: 10.1517/14712598.2014.912270. Review.

PMID:
24762115
16.

Possible therapeutic targets among the molecules involved in the Warburg effect in tumor cells.

Nam SO, Yotsumoto F, Miyata K, Shirasu N, Miyamoto S, Kuroki M.

Anticancer Res. 2013 Jul;33(7):2855-60. Review.

PMID:
23780970
17.

Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy.

Scatena R, Bottoni P, Pontoglio A, Giardina B.

Proteomics Clin Appl. 2010 Feb;4(2):143-58. doi: 10.1002/prca.200900157. Review.

PMID:
21137040
18.

Metabolic alterations in cancer cells and therapeutic implications.

Hammoudi N, Ahmed KB, Garcia-Prieto C, Huang P.

Chin J Cancer. 2011 Aug;30(8):508-25. doi: 10.5732/cjc.011.10267. Review.

19.

Energy metabolism in tumor cells.

Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E.

FEBS J. 2007 Mar;274(6):1393-418. Review.

20.

Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.

Ebbesen P, Pettersen EO, Gorr TA, Jobst G, Williams K, Kieninger J, Wenger RH, Pastorekova S, Dubois L, Lambin P, Wouters BG, Van Den Beucken T, Supuran CT, Poellinger L, Ratcliffe P, Kanopka A, Görlach A, Gasmann M, Harris AL, Maxwell P, Scozzafava A.

J Enzyme Inhib Med Chem. 2009 Apr;24 Suppl 1:1-39. doi: 10.1080/14756360902784425. Review.

PMID:
19330638
Items per page

Supplemental Content

Support Center